Details for New Drug Application (NDA): 018795
✉ Email this page to a colleague
NDA 018795 describes LOCOID, which is a drug marketed by Bausch, Yamanouchi, and Precision Dermat, and is included in eight NDAs. It is available from two suppliers. There is one patent protecting this drug and two Paragraph IV challenges. Additional details are available on the LOCOID profile page.
The generic ingredient in LOCOID is hydrocortisone butyrate. There are sixty-seven drug master file entries for this compound. Six suppliers are listed for this compound. Additional details are available on the hydrocortisone butyrate profile page.
The generic ingredient in LOCOID is hydrocortisone butyrate. There are sixty-seven drug master file entries for this compound. Six suppliers are listed for this compound. Additional details are available on the hydrocortisone butyrate profile page.
Summary for 018795
| Tradename: | LOCOID |
| Applicant: | Yamanouchi |
| Ingredient: | hydrocortisone butyrate |
| Patents: | 0 |
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | CREAM;TOPICAL | Strength | 0.1% | ||||
| Approval Date: | Jan 7, 1983 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
